Gluten-free diet in a law trap: how long will celiac patients wait to see a change of the legislation?
Authors:
P. Makovický 1; G. Samasca 2; H. J. Freeman 3; P. Makovický 4
Authors‘ workplace:
Laboratórium veterinárnej histopatológie v Komárne, Slovenská republika
1; Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania
2; Department of Medicine (Gastroenterology), Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
3; Katedra biológie, Pedagogická fakulta, Univerzita J. Selyeho, Komárno, Slovenská republika
4
Published in:
Reviz. posud. Lék., 20, 2017, č. 2, s. 65-73
Category:
Original Articles, Review Articles, Case Reports
Overview
A gluten-free diet represents the only therapy available for celiac disease, an immune-mediated small intestinal mucosal disorder that occurs in genetically-predisposed persons. By definition, a gluten-free diet assumes that each food component is gluten-free, or alternatively, that all pre-existing gluten has been secondarily removed from the food prior to dietary consumption. Even a small amount of gluten may be toxic and may launch an immune reaction that causes morphological change in the cellular level of the small bowel mucosa. We are presenting legislative proposal that would eventually be improved to clarify the production of gluten-free foods. Then, we propose some changes in the social system, including social support for people with celiac disease. Authorities with decision making and legislative power need to consider the impact of celiac disease in their nations, and the importance of providing support to affected individuals.
Keywords:
gluten-free diet – celiac disease – legislative – gluten – cereals – nutrition
Sources
1. Abenavoli, L., Delibasic, M., Peta, V. et al. Nutritional profile of adult patients with celiac disease. Eur. Rev. Med. Pharmacol. Sci., 2015, 22, p. 4285–4292.
2. Bascunán, K. A., Vespa, M. C., Araya, M. Celiac disease: understanding the gluten-free diet. Eur. J. Nutr., 2017, in press.
3. Bold, J., Rostami, K. Gluten tolerance; potential challenges in treatment strategies. Gastroenterol. Hepatol Bed Bench, 2011, 2, p. 53–57.
4. Brychta, J., Honzlová, A., Bulawová, H. et al. Výsledky kontroly vybraných jakostních ukazatelů u masných výrobků. Maso, 2014, 6, p. 36–39.
5. Freeman H. J. Emerging drugs for celiac disease. Expert Opin. Emerg. Drugs, 2015, 1, p. 129–135.
6. Frič, P., Zavoral, M., Dvořáková, T. Choroby způsobené lepkem. Vnitr. Lek., 2013, 5, p. 367–382.
7. Green, P. H., Lebwohl, B., Greywoode, R. Celiac disease. J. Allergy Clin. Immunol., 2015, 5, p. 1099–1106.
8. Gregar, I., Kolek, A., Kojecký, Z. et al. Celiakie dospělých – klinické projevy a přidružená onemocnění. Prakt. Lek., 2000, 11, p. 617–620.
9. Guerdrum, L. J., Bamforth, C. W. Levels of gliadin in comercial beers. Food Chem., 2011, 4, p. 1783–1784.
10. Hollon, J. R., Cureton, P. A., Martin, M. L. et al. Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol., 2013, 13, p. 40.
11. Koerner, T. B., Cleroux, C., Poirier, C. et al. Gluten contamination of naturally gluten-free fluors and starches used by Canadians with celiac disease. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess., 2013, 12, p. 2017–2021.
12. Kohout, P. Celiakie v ambulantní praxi. Med. pro Praxi, 2007, 6, p. 250–252.
13. La Vieille, S., Dubois, S., Hayward, S. et al. Estimated Levels of Gluten Incidentally Present in a Canadian Gluten-Free Diet. Nutrients, 2014, 2, p. 881–896.
14. Lebwohl, B., Ludvigsson, J. F., Green, P. H. Celiac disease and non-celiac gluten sensitivity. BMJ, 2015, 351, p. 4347.
15. Lee, H. J., Anderson, Z., Ryu, D. Gluten contamination in foods labelled as “gluten free” in the United States. J. Food Prot., 2014, 10, p. 1830–1833.
16. Ludvigsson, J. F., Leffler, D. A., Bai, J.C. et al. The Oslo definitions for coeliac disease and related terms. Gut, 2013, 1, p. 43–52.
17. Lupan, I., Sur, G., Deleanu, D. et al. Celiac disease microbiota and its applications. Ann. Microbiol., 2014, 3, p. 899–903.
18. Majerová, E. et al. Starostlivosť o pacienta s celiakiou. Košice: Elfa, s. r. o., 2009, s. 71. ISBN 978-80-8086-112-4.
19. Makovický, P., Kulíšek, V., Haščík, P. et al. Charakteristika patogenézy a symptómov primárnej malabsorbcie z hľadiska historického monitoringu jej vývoja. Slov. Vet. Cas., 2004, 1, p. 29–31.
20. Makovický, P., Makovický, P., Greguš, M. et al. Histopatologická diagnostika celiakie u dospelých s funkčným dyspeptickým syndrómom. Cesk. Patol., 2008, 1, p. 16–19.
21. Makovický, P., Makovický, P., Jílek, F. Od historických poznatkov a názorov až po súčasné úlohy na poli celiakie. Epidemiol. Mikrobiol. Imunol., 2008, 3, p. 90–96.
22. Makovický, P., Makovický, P., Maxová, M. Typical and atypical forms of celiac disease from a pathologist viewpoint. Cesk.-Slov. Gastroenterol. Hepatol., 10. vzdělávací a diskusní gastroenterologické dny. 2008, S 3, 23.
23. Makovický, P., Makovický, P., Maxová, M. Možnosti diagnostiky celiakie v bioptickej praxi. Cesk. Patol., 2009, 1, s. 14–18.
24. Makovický, P., Makovický, P. Od diagnostiky celiakie až k možnostiam legislatívnych zmien. Vnitr. Lek., 2009, 6, s. 583–586.
25. Makovický, P., Rimárová, K. Význam a možnosti skríningu v diagnostike celiakie. Vnitr. Lek., 2011, 2, p. 183–187.
26. Makovický, P., Samasca, G. Present view of the management and tasks in the celiac disease field: From diagnosis to therapy. Int. J. Celiac Dis., 2013, 1, p. 3–5.
27. Makovický, P. A dialogue with Professor Hugh Freeman. Int. J. Celiac Dis., 2016, 3, p. 105–108.
28. Makovický, P., Makovický, P., Lupan, I. et al. Gluten-free products for patients with celiac disease should not contain trace levels. Adv. Nutr., 2017, in press.
29. Malamut, G., Cellier, C. Complications of coeliac disease. Best Pract. Res. Clin. Gastroenterol., 2015, 3, p. 451–458.
30. McCarville, J. L., Caminero, A., Verdu, E. F. Pharmacological approaches in celiac disease. Curr. Opin. Pharmacol., 2015, 12, p. 7–12.
31. Pekárková, B., Pekárek, B., Kabátová, J. Štandardný diagnostický a terapeutický postup. 46. Metodický list racionálnej farmakoterapie. Racionálna diagnostika a liečba celiakie, 2009, 13, p. 1–2.
32. Pham-Short, A., Donaghue, K. C., Ambler, G. et al. Screening for Celiac disease in type 1 Diabetes: a Systematic review. Pediatrics, 2015, 136, p. 170–176.
33. Prokešová, J. Celiakální sprue – staronová diagnóza. Reviz. Posud. Lék., 2013, 3, s. 95–100.
34. Reilly, N. R. The gluten-free diet: Recognizing facts, fiction, and fad. J. Pediatr., 2016, 175, p. 206–210.
35. Rimárová, K. et al. Celiakia choroba a dieta. Košice: Elfa, s. r. o., 2008, p. 133. ISBN 978-80-8086-095-0.
36. Rimárová, K., Makovický, P. Význam a možnosti skríningu pri typických a atypických formách celiakie. Gastroenterol. Pre Prax, 2010, 2, p. 85–87.
37. Saccone, G., Berghella, V., Sarno, L. et al. Celiac disease and obstetric complications: a systematic review and metaanalysis. Am. J. Obst. Gynecol., 2016, 2, p. 225–234.
38. Samasca, G., Lupan, I., Deleanu, D. et al. Immunological approach of the challenges of the XXI century in celiac disease. Int. Rev. Immunol., 2014, 1, p. 3–8.
39. Samasca, G. A dialogue with Professor Michael N. Marsh. Int. J. Celiac Dis., 2016, 2, p. 34–37.
40. Samasca, G. A dialogue with Professor Aaron Lerner. Int. J. Celiac Dis., 2016, 3, p. 109–112.
41. See, J. A., Kaukinen, K., Makharia, G. K. et al. Practical insight into gluten-free diets. Nat. Rev. Gastroenterol. Hepatol., 2015, 10, p. 580–591.
42. Sharma, G. M., Pereira, M., Williams, K. M. Gluten detection in foods available in the United States - A market survey. Food Chem., 2015, 169, p. 120–126.
43. Simpson, S., Thompson, T. Nutrition assessment in celiac disease. Gastrointest. Endosc. Clin. N. Am., 2012, 4, p. 797–809.
44. Stacke, J. Posudková problematika u dětí s celiakií. Reviz. posud. Lék., 2010, 1, s. 9–19.
45. Surojanametakul, V., Srikulnath, S., Chamnansin, P. et al. Survey of Thai Commercial Food Products That Have Been Reported to Contain No Wheat, Rye, Barley, or Gluten According to Their Labels. J. AOAC Int., 2017, 1, p. 126–132.
46. Thompson, T., Lee, A. R., Grace T. Gluten contamination of grains, seeds, and fours in the United States: a pilot study. J. Am. Diet. Assoc., 2010, 6, p. 937–940.
47. Verma, A. K., Gatti, S., Galeazzi, T. et al. Gluten contamination in naturally or labelled gluten-free products marketed in Italy. Nutrients, 2017, 2, E115.
48. Vido, Ľ., Guľovic, J., Juriš, P. Výsledky cielených control potravinových alergénov v Košickom kraji – 2 časť. Slov. Vet. Cas., 2009, 2, p. 78–81.
49. Zanini, B., Marullo, M., Villanacci, V. et al. Persistent intra-epithelial lymphocytosis in Celiac disease patients adhering to gluten-free diet is not abolished despite a gluten contamination elimination diet. Nutrients, 2016, 9, E525.
50. Zimmer, K. P. Nutrition and celiac disease. Curr. Probl. Pediatr. Adolesc. Health Care, 2011, 9, p. 344–247.
Labels
Medical assessment Occupational medicineArticle was published in
Medical Revision
2017 Issue 2
Most read in this issue
- Assertiveness
- Adaptation in the old age in relation to health state and a degree of dependence and ethical values in the evaluation of the degree of dependence
- Employment of persons with health disability
- Gluten-free diet in a law trap: how long will celiac patients wait to see a change of the legislation?